890123-55-4

Basic information

• Product Name: (S)-2-[2-bromo-1-(4-methoxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide
• Synonyms: (S)-2-[2-bromo-1-(4-methoxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide
• CAS NO: 890123-55-4
• Molecular Weight: 332.281
• Mol File: 890123-55-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (S)-2-[2-bromo-1-(4-methoxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-[2-bromo-1-(4-methoxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide(890123-55-4)
• EPA Substance Registry System: (S)-2-[2-bromo-1-(4-methoxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide(890123-55-4)

Safety Data

• Hazardous Substances Data: 890123-55-4(Hazardous Substances Data)

Upstream product

• 51326-00-2 2-bromo-3-ethoxycyclohex-2-en-1-one 
• 5323-87-5 3-Ethoxycyclohex-2-en-1-one 
• 17913-18-7 4-(methoxy)-1-chlorobutane 
• 890123-53-2 2-bromo-3-(4-methoxybutyl)cyclohex-2-en-1-one 
• 890123-54-3 (R)-2-bromo-3-(4-methoxybutyl)cyclohex-2-en-1-ol 
• 18871-66-4 N,N-dimethylacetamide dimethyl acetal 

Downstream Products

• 890123-59-8 methyl (S)-4-[1-(2-methoxy-2-oxoethyl)cyclohex-2-en-1-yl]butanoate 
• 890123-57-6 (S)-2-[1-(4-hydroxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide 
• 890123-56-5 (S)-2-[1-(4-methoxybutyl)cyclohex-2-en-1-yl]-N,N-dimethylacetamide 

Relevant articles and documents

Synthesis of spiro[4.5]decane CF-ring analogues of 1α,25- dihydroxyvitamin D3

(Chemical Equation Presented) A novel series of analogues of calcitriol (1) is developed featuring a spirocyclic central core resulting from C18/C21-connection and C15/ C16-deletion (2a, 2b). The synthesis of the key intermediate involves an Eschenmoser r

7-(2-CYCLOHEXYLIDENE-ETHYLIDENE)-SPIRO[5.5]UNDECANES USEFUL FOR MAKING PHARMACEUTICAL COMPOSITIONS

The invention relates to novel analogues of the hormonally active metabolite of vitamin D3, and more specifically provides 7- (2-cyclohexylidene-ethylidene) -spiro [5.5] undecanes and methods for making them, as well as pharmaceutical compositions which c